Global Transfection Reagents & Equipment Market Analysis, Drivers, Restraints, Opportunities, Threats, Trends, Applications, and Growth Forecast to 2029
“Global Transfection Reagents & Equipment Market” is the title of an upcoming report offered by MarketResearch.Biz. The report contains information and data, and inputs from both primary and secondary data sources, that have been verified and validated by experts in the target market. The report presents a thorough study of revenues, historical data, and information, key developments, and strategies by major players that offer vital insights and perspectives in to various scenarios market. Besides critical data and related information, the report includes key trends (both present and future), factors that are driving market growth, factors that are or could be potential restraints to market growth, as well as opportunities that can be leveraged for potential revenue generation in untapped regions and countries. It also covers threats or challenges for existing as well as new entrants in the market. The global transfection reagents & equipment market has been segmented on the basis of product, method, application, as well as regions and countries.
Transfection refers to the introduction of any nucleic acid molecule by non-viral means into cultured eukaryotic cells. The main purpose of transfection is to study the function of genes or gene products, by enhancing or inhibiting specific gene expression cells, to produce recombinant proteins in mammalian cells. Although there are many ways to deliver genes to cells, there are three primary recognized methods – chemical reagents, electroporation (gene electrotransfer), and viral transduction.
The surging application of transfection practices by academic researchers, as well as the various developments in the field of proteomics and recombinant technology are some of the primary factors that are expected to have a profound impact on the revenue growth of the global transfection reagents & equipment market over the next 10 years.
Moreover, the increasing launch of varying novel reagents and systems targeted at large-scale transient transfection of suspension lines, that can perform an efficient transfection in any type of cell is also a factor that is slated to boost the future market growth of this global industry.
However, in light of the recent COVID-19 outbreak, the operations of numerous industries have been either temporarily halted or are functioning with a minimal workforce due to enforced lockdowns and imposed restrictions by respective governing bodies. The global transfection reagents & equipment industry is no different, and this factor is expected to negatively impact on market growth in the years to come.
Nonetheless, the growing number of cancer research programs being undertaken that is focused on cancer management is another factor that is anticipated to compliment the revenue growth of the global transfection reagents & equipment market in the foreseeable future.
Segmentation of the global transfection reagents & equipment market is as follows:
In terms of product, the reagents segment accounted for the maximum number of revenue shares of the global transfection reagents & equipment market in 2020, and is indicative of continuing to do so in the years to come. The equipment segment is also slated to index considerable revenue growth over the forecast period.
On the basis of method, the electroporation segment constituted the majority number of revenue shares of the global transfection reagents & equipment market in 2020, due to the wide range of electroporation solutions that are offered by both existing players and new market entrants. The liposomal and particle bombardment segments accounted for the second-, and third-most number of revenue shares in 2020.
With regards to application, the gene expression studies segment accounted for the maximum number of revenue shares of the global transfection reagents & equipment market in 2020, owing to the increasing emphasis on the translation of genomic information in clinical workflows, as well as the expansion of the genomic data pool. Additionally, the biomedical research segment is also slated to index considerable revenue growth in the coming years.
Regional Segmentation and Analysis:
North America accounted for the highest number of revenue shares of the global transfection reagents & equipment market in 2020, and is slated to continue to do so over the forecast period. This can be attributed to the vast number of market players in this region, as well as increasing funding towards R&D activities on cancer therapeutics, advanced cytological studies, and precision medicine. However, the markets in the Asia Pacific are also anticipated to register high revenue growth over the next 10 years, owing to factors such as increasing healthcare expenditures, a growing patient pool, etc.
Segmentation of the Global Transfection Reagents & Equipment Market:
Segmentation by Product:
Segmentation by Method:
- Particle Bombardment
- Adenoviral Vectors
- Calcium Phosphate
- Magnetic Beads
- Activated Dendrimers
Segmentation by Application:
- Gene Expression Studies
- Protein Production
- Transgenic Models
- Therapeutic Delivery
- Cancer Research
- Biomedical Research
Segmentation by Regions:
- North America
- South America
Attribute Report Details Market Size Ask For Market Size Growth Rate Ask For Growth Rate Key Companies Ask For Companies Report Coverage Revenue analysis, Competitive landscape, Key company analysis, Market Trends, Key segments, Distribution Channel, Market Dynamics, COVID-19 Impact Analysis and more… Historical Data Period 2015-2020 Base Year 2022 Forecast Period 2022-2031 Region Scope North America, Europe, Asia-Pacific, South America, Middle East & Africa Country Scope United States, Canada and Mexico, Germany, France, UK, Russia and Italy, China, Japan, Korea, India and Southeast Asia, Brazil, Argentina, Colombia etc.Saudi Arabia, UAE, Egypt, Nigeria and South Africa Revenue in US$ Mn
- Thermo-Fisher Scientific Inc.
- Promega Corporation
- Lonza Group
- Hoffmann-La Roche Ltd.
- Bio-Rad Laboratories Inc.
- Merck KGaA
- OriGene Technologies Inc.
- MaxCyte Inc.
- POLYPLUS-TRANSFECTION SA
- Horizon Discovery Ltd.
- PromoCell GmbH.
Request for TOC
Why Choose Us
- 360 Degree Approach
- Growth Consulting
- 24/7 Research Support
- Comprehensive-Level of Customization
- Comprehensive-Level of Customization
- Competitive Intelligence
- Single-Country/ Region Intelligence
- Post-Sale Service Assistance
- Access to Lead Analysts
- Available in PDF, Excel, Word/ PPT
Request for Customization
Don't just take our word. We are trusted by these great companies!